Physician profile
Benjamin L Cho
NPI 1245360759
$487.63
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $11.75 · 2021: $41.96 · 2022: $120 · 2023: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $136 · Education: $72.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.56 |
| Education | $72.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $135.56 | 2023 | Enhertu |
| Biocompatibles, INC. | $94.20 | 2019 | |
| Glaxosmithkline, LLC. | $93.23 | 2022 | |
| Gilead Sciences, INC. | $84.65 | 2021-2023 | Trodelvy |
| E.R. Squibb & Sons, L.L.C. | $41.79 | 2020-2021 | |
| Foundation Medicine, INC. | $26.42 | 2022 | |
| Genentech USA, INC. | $11.78 | 2019 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.